Angion Biomedica Corp. (ANGN)
NASDAQ: ANGN
· Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM
Angion Biomedica Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 653K | 2.3M | 28.24M | 29.7M | 29.59M | 28.31M | 2.83M | 2.2M | 2.39M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 433K | 433K | 433K | 433K | 126K | 474K | 807K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | 653K | 2.3M | 27.81M | 29.27M | 29.16M | 27.88M | 2.7M | 1.72M | 1.58M |
Operating Income | -53.84M | -53.87M | -39.82M | -34.08M | -30.21M | -28.48M | -29.74M | -39.62M | -15.83M | -22.54M | -31.75M | -37.2M | -67.79M | -63.62M | -62.64M |
Interest Income | 555K | 591K | 607K | 891K | 754K | 508K | 469K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -66.42M | -65.87M | -44.28M | -29.98M | -29.19M | -27.52M | -29.1M | -38.81M | -17.48M | -24.19M | -32.13M | -54.57M | -98.34M | -100.3M | -103.57M |
Net Income | -66.49M | -65.94M | -44.28M | -29.91M | -34.19M | -38M | -39.58M | -49.36M | -24.8M | -26.04M | -33.97M | -56.42M | -98.34M | -100.3M | -103.57M |
Selling & General & Admin | 9.55M | 10.1M | 12.22M | 13.37M | 14.37M | 14.17M | 14.96M | 15.14M | 15.6M | 16.22M | 16.94M | 18.49M | 17.4M | 19.45M | 20.54M |
Research & Development | 44.29M | 43.77M | 27.6M | 20.71M | 12.69M | 8.37M | 9.5M | 20.84M | 27.35M | 37.7M | 46.07M | 48.7M | 53.09M | 45.89M | 43.68M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 433K | 433K | 433K | 433K | n/a | n/a | n/a |
Operating Expenses | 53.84M | 53.87M | 39.82M | 34.08M | 27.06M | 22.54M | 24.45M | 35.98M | 43.38M | 54.35M | 63.44M | 67.62M | 70.5M | 65.34M | 64.22M |
Interest Expense | -32K | 143K | -901K | -834K | -383K | -123K | 591K | 661K | 2.11M | 1.96M | 2.08M | -89K | -10.78M | -10.89M | -11.02M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.83M | 32.6M | 18.55M | 23.16M | 27.06M | 22.54M | 24.45M | 35.98M | 43.81M | 54.78M | 63.88M | 68.05M | 70.62M | 65.81M | 65.03M |
Income Tax Expense | 70K | 70K | n/a | -70K | 5M | 10.48M | 10.48M | 10.55M | 7.33M | 1.9M | 1.9M | 1.9M | 54K | n/a | n/a |
Shares Outstanding (Basic) | 12.95M | 12.2M | 13.58M | 21.85M | 25.98M | 25.98M | 30.11M | 30.04M | 30.11M | 29.97M | 29.96M | 29.83M | 29.83M | 29.67M | 23.44M |
Shares Outstanding (Diluted) | 12.95M | 12.2M | 13.58M | 21.85M | 25.98M | 25.98M | 30.11M | 30.04M | 30.11M | 29.97M | 29.96M | 29.83M | 29.83M | 29.67M | 23.44M |
EPS (Basic) | -4.98 | -4.52 | -2.42 | -1.18 | -1.23 | -1.3 | -1.31 | -1.64 | -0.82 | -0.87 | -1.15 | -2.23 | -3.67 | -4.19 | -4.81 |
EPS (Diluted) | -4.98 | -4.52 | -2.42 | -1.18 | -1.23 | -1.3 | -1.31 | -1.64 | -0.82 | -0.87 | -1.15 | -2.23 | -3.67 | -4.19 | -4.81 |
EBITDA | -61.03M | -61.06M | -39.82M | -33.95M | -23.76M | -22.04M | -23.29M | -33.22M | -15.53M | -22.24M | -31.45M | -36.98M | -68.27M | -70.04M | -71.97M |
EBIT | 18.93M | 8.27M | -18.93M | -23.54M | -29.58M | -27.65M | -19.37M | -14.77M | 10.11M | 3.25M | -13.7M | -52.56M | -109.12M | -93.53M | -76.58M |
Depreciation & Amortization | -207.5K | -247.09K | 82.5K | 207.5K | 6.53M | 12.66M | 12.77M | 12.87M | 6.77M | 900K | 874K | 801K | 724K | 648K | 612K |